Protagonist Therapeutics

Protagonist Therapeutics: Proprietary peptide technology platform to develop oral targeted therapy-based drugs and injectables for rare diseases. PTG-300 injectable hepcidin mimetic Ph 2 trials ongoing in polycythemia vera and hereditary hemochromatosis; positive updated Ph 2 results in PV presented at ASH 2020. PN-943 oral GI-restricted alpha-4-beta-7 antagonist Ph 2 in ulcerative colitis study sites activated; PTG-200, partnered w/ Janssen, oral GI-restricted IL-23R antagonist Ph 2 Crohn’s disease study ongoing.
Based in...
US - Pacific
Clinical Stage
Phase l or ll
Disease Space
Anti-inflammatory, Autoimmune, Gastrointestinal, Rare Disease
Public, USA
Market Cap
1B +
Therapeutic Modalities
Platform Technology
521 Cottonwood Drive
Suite 100
Milpitas, CA 95035
United States

Company Participants at Solebury Trout Virtual Management Access Event - 1x1 conference calls

  • Dinesh V Patel, PhD, President & CEO

Top 10 Holders of Protagonist Therapeutics, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Fidelity Management & Research Co. LLC 14.91 6,532,340 258.94 13F 3/31/21
BVF Partners LP 9.99 4,273,588 169.41 Stakes 12/31/20
BVF, Inc. 9.04 3,959,451 156.95 13F 3/31/21
RTW Investments LP 8.01 3,507,390 139.03 13F 3/31/21
Consonance Capital Management LP 6.19 2,709,709 107.41 13F 3/31/21
Johnson & Johnson Innovation JJDC, Inc. 5.59 2,449,183 97.09 13F 3/31/21
Farallon Capital Management LLC 5.54 2,425,000 96.13 13F 3/31/21
The Vanguard Group, Inc. 4.72 2,073,727 82.20 Funds 4/30/21
Vanguard Group, Inc. (Subfiler) 4.63 2,027,647 80.38 13F 3/31/21
State Street Corp. 3.91 1,712,683 67.89 13F 3/31/21
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2021 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.